2022
DOI: 10.1016/j.jclinepi.2022.07.014
|View full text |Cite
|
Sign up to set email alerts
|

GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
45
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(54 citation statements)
references
References 16 publications
(29 reference statements)
0
45
0
Order By: Relevance
“…Two reviewers reached consensus through discussion on the certainty about conclusions in relation to our thresholds of effect of the relative effects for each outcome, guided by GRADE. [21, 22] We started the evidence at high certainty [23] and down rated to lower levels (i.e., moderate, low, and very low certainty) based on study quality in five domains (i.e., risk of bias, indirectness, inconsistency, imprecision, reporting biases). For each domain, we rated down by 0, 1, or 2 levels depending on the seriousness of the concerns, i.e., how much the domain appeared to impact the conclusions.…”
Section: Methodsmentioning
confidence: 99%
“…Two reviewers reached consensus through discussion on the certainty about conclusions in relation to our thresholds of effect of the relative effects for each outcome, guided by GRADE. [21, 22] We started the evidence at high certainty [23] and down rated to lower levels (i.e., moderate, low, and very low certainty) based on study quality in five domains (i.e., risk of bias, indirectness, inconsistency, imprecision, reporting biases). For each domain, we rated down by 0, 1, or 2 levels depending on the seriousness of the concerns, i.e., how much the domain appeared to impact the conclusions.…”
Section: Methodsmentioning
confidence: 99%
“…Accordingly, we judged the pooled effect for EVT alone versus combination therapy as imprecise as the 95% CI ranged from 5.4% more to 2.5% less recovering with no impairment; a range that includes both important benefits and harms associated with EVT alone and thus warranted rating down twice for imprecision according to the GRADE approach. 38 The ESO–ESMINT guideline, alternatively, applied a non-inferiority margin of 1.3% and concluded that non-inferiority was not met and did not rate down for imprecision. The same issue affected the assessment of mortality.…”
Section: Resultsmentioning
confidence: 99%
“…The current meta-epidemiological study attempted to align with the recent GRADE guidance about imprecision 29. This GRADE guidance about minimally contextualised imprecision relates the CI of the pooled estimate to a threshold that is considered by stakeholders to be clinically important, and de-emphasises the null as a threshold of importance.…”
Section: Discussionmentioning
confidence: 99%